Mallinckrodt Pharmaceuticals
MNK
$0.34
Share price
0.00%
Change (1 day)
-93.81%
Change (1 year)
Categories
EPS for Mallinckrodt Pharmaceuticals (MNK)
EPS in 2023 (TTM): -$121.08
According to Mallinckrodt Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -$121.08. In 2021 the company made an earnings per share (EPS) of -$8.47 an increase over its 2020 EPS that were of -$11.19.
EPS history for Mallinckrodt Pharmaceuticals from 2013 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$121.08 | |
| 2021 | -$8.47 | -24.31% |
| 2020 | -$11.19 | -5.41% |
| 2019 | -$11.83 | -72.67% |
| 2018 | -$43.29 | -291.46% |
| 2017 | $22.61 | 797.22% |
| 2016 | $2.52 | -34.03% |
| 2015 | $3.82 | -207.61% |
| 2014 | -$3.55 | -366.73% |
| 2013 | $1.33 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $14.09 | -111.63% | 🇺🇸 USA |
 General Electric GE | $8.55 | -107.06% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | -$2.00 | -98.35% | 🇮🇱 Israel |